UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study)
Conditions: COVID-19 Pandemic; COVID-19 Vaccines; COVID-19 Virus Disease Interventions: Biological: INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 μg Sponsors: Dr. Soetomo General Hospital; Universitas Airlangga; Biotis Pharmaceuticals, Indonesia; Indonesia-MoH Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Covid Vaccine | COVID-19 | Hospitals | Indonesia Health | Pandemics | Research | SARS | Study | Vaccines